ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
BriaCell Therapeutics Corporation

BriaCell Therapeutics Corporation (BCTX)

4.35
0.34
(8.48%)
Closed April 13 4:00PM
4.5899
0.2399
(5.51%)
After Hours: 7:55PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.5899
Bid
1.11
Ask
7.00
Volume
27,494
4.07 Day's Range 4.40
3.00 52 Week Range 42.7485
Market Cap
Previous Close
4.01
Open
4.10
Last Trade
2
@
4.5
Last Trade Time
Financial Volume
$ 116,600
VWAP
4.2409
Average Volume (3m)
409,943
Shares Outstanding
2,946,940
Dividend Yield
-
PE Ratio
-6.52
Earnings Per Share (EPS)
-1.63
Revenue
-
Net Profit
-4.79M

About BriaCell Therapeutics Corporation

BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination... BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC). MBC is breast cancer that has spread to other tissues. Bria-IMT(TM) is a targeted cell-based immunotherapy. Additionally, BriaCell is developing, Bria-OTS(TM), a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical study initially targeting breast cancer, with extension to prostate cancer, and other cancers. Show more

Sector
Aircraft
Industry
Business Services, Nec
Headquarters
Vancouver, British Columbia, Can
Founded
2009
BriaCell Therapeutics Corporation is listed in the Aircraft sector of the NASDAQ with ticker BCTX. The last closing price for BriaCell Therapeutics was $4.01. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 3.00 to $ 42.7485.

BriaCell Therapeutics currently has 2,946,940 shares outstanding. The market capitalization of BriaCell Therapeutics is $11.82 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -6.52.

BCTX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.089931.143.54.58993.34511673.93515623CS
40.859923.05361930293.734.78093.34466713.98749189CS
12-1.4101-23.501666666767.8734099434.90980942CS
26-10.5601-69.70363036315.1519.05395697010.4886334CS
52-36.2101-88.75024509840.842.74853174583410.77096708CS
156-172.4101-97.4068361582177178.4985374705930.92642889CS
260-59.0101-92.783176100663.6187.053110430865.64360425CS

BCTX - Frequently Asked Questions (FAQ)

What is the current BriaCell Therapeutics share price?
The current share price of BriaCell Therapeutics is $ 4.5899
How many BriaCell Therapeutics shares are in issue?
BriaCell Therapeutics has 2,946,940 shares in issue
What is the market cap of BriaCell Therapeutics?
The market capitalisation of BriaCell Therapeutics is USD 11.82M
What is the 1 year trading range for BriaCell Therapeutics share price?
BriaCell Therapeutics has traded in the range of $ 3.00 to $ 42.7485 during the past year
What is the PE ratio of BriaCell Therapeutics?
The price to earnings ratio of BriaCell Therapeutics is -6.52
What is the reporting currency for BriaCell Therapeutics?
BriaCell Therapeutics reports financial results in USD
What is the latest annual profit for BriaCell Therapeutics?
The latest annual profit of BriaCell Therapeutics is USD -4.79M
What is the registered address of BriaCell Therapeutics?
The registered address for BriaCell Therapeutics is SUITE 300 - 235 WEST 15TH STREET, VANCOUVER, BRITISH COLUMBIA, V7T 2X1
What is the BriaCell Therapeutics website address?
The website address for BriaCell Therapeutics is www.briacell.com
Which industry sector does BriaCell Therapeutics operate in?
BriaCell Therapeutics operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSPRMSP Recovery Inc
$ 2.479
(93.67%)
87.38M
PRTGPortage Biotech Inc
$ 8.5091
(66.85%)
31.29M
WTOUTime Limited
$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
$ 2.09
(48.23%)
13.81M
THTXTheratechnologies Inc
$ 1.94
(45.86%)
49.4M
TOROVToro Corporation
$ 1.43
(-82.48%)
109.39k
LUCYInnovative Eyewear Inc
$ 2.3471
(-52.58%)
1.98M
XHGXChange TED Inc
$ 0.1985
(-45.71%)
8.7M
MULNMullen Automotive Inc
$ 2.18
(-39.44%)
4.35M
FLDFold Holdings Inc
$ 2.6601
(-33.50%)
1.74M
DMNDamon Inc
$ 0.003
(-28.57%)
1.08B
BONBon Natural Life Ltd
$ 0.066
(8.73%)
658M
STSSSharps Technology Inc
$ 0.0245
(33.88%)
653.02M
NVDANVIDIA Corporation
$ 110.93
(3.12%)
313.46M
LGMKLogicMark Inc
$ 0.009699
(3.18%)
264.71M

BCTX Discussion

View Posts
Invest-in-America Invest-in-America 2 months ago
BCTX: Roger that, Capt.!!
👍️0
tw0122 tw0122 2 months ago
$3.83 + 10% Super low float power 3.33 52 week low ...on watch add a few for now 
👍️0
axelvento axelvento 2 months ago
priced a best-efforts public offering of 762,500 common shares at $4.00 per share, with expected gross proceeds of $3.05 million before fees and expenses.
👍️0
tedgoeseast tedgoeseast 2 months ago
Hahahaha 🤣😂
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: I.e., where their 'Investigational Drug Group' consisted of 400-PATIENTS --- vs. merely just ONE, as in their bogus PR today!!!
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: Could you imagine where the PRICE of this stock would be right now, if this Firm had PR'd legitimate STATISTICS to the effect that 75% of the 'Investigational Drug Group' enjoyed 100% remission of their metastasized LUNG CANCERS --- when compared to the 'Placebo Group", & all other 'Control Groups' & 'Standard of Care Groups'??? (And moreover, this HOAX Company did NOT even entertain ANY 'Control Groups', nor 'Standard of Care Groups', AT ALL!!! Their only experimental 'competition', as it were, was a useless 'PLACEBO GROUP'!!! I myself KNOW this stuff, Peeps!!! Anyone who got suckered by the conspicuous NONSENSE within BCTX's PR today, is patently-STUPID --- even when compared to all universal, 'Standards of Stupidity!!!)


"Tell-it-like-it-is, Oh Great Invest-in-America, Dude!!! You're doing GOD's work, Homeboy!!!"
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: At least I can recognized a HOAX, when I see one!! (And they even PR'd a cute 'X-RAY' too, of a TINY SPOT of purported metastasized CANCER that had suddenly disappeared behind their disruptive new ELIXIR!!!)
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
THE BIO BEAST OF THE DAY...DILUTION WILL KICK IN NOW
👍️0
tw0122 tw0122 2 months ago
One patient all it takes $6.75 .. .."That's one small step for man, one giant leap for mankind." However, Armstrong insisted that he actually said, "That's one small step for a man," though the "a" was not clearly heard in the transmission...
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: Straight-up HOAX!!! (Such a PR is never, never, never DONE behind one patient!!!)
👍️0
glenn1919 glenn1919 2 months ago
BCTX........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
tedpeele tedpeele 2 months ago
does seem questionable -- certainly a very impressive result -- but one person only --- abberations do occur
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: Their purported NEWS is a "Statistical Artifact" --- significant of NOTHING!!! No legitimate Pharma firm would ever PR such (One Patient) crap!!!
👍️0
tedpeele tedpeele 2 months ago
I'm seeing 2.7m float
👍️0
Invest-in-America Invest-in-America 2 months ago
BCTX: Something very CREEPY here, Peeps!!! (Be careful!!)
👍️0
axelvento axelvento 2 months ago
huge news-Treatment with Bria-OTS™ monotherapy resulted in 100% resolution of tumor in the lung of the MBC patient following 4 injection cycles


This 78-year-old woman with metastatic breast cancer (hormone receptor positive, HER2 negative) had failed several prior lines of therapy and received the lowest dose level in the Phase 1/2a Bria-OTS™ study. At enrollment on Nov 21, 2024, she had extensive metastases including multiple bone, lymph node and lung metastases. Following 4 injections with Bria-OTS™ every 2 weeks, the lung metastasis completely resolved, and she had stable disease elsewhere.

https://feeds.issuerdirect.com/news-release.html?newsid=7417246418288908
💪 1 💯 1
Invest-in-America Invest-in-America 2 months ago
BCTX: One patient cured. (Warrants here??)
👍️0
tw0122 tw0122 2 months ago
BCTX $5.90 + 16% 20m floater but news is decent..

👍️0
TrendTrade2016 TrendTrade2016 2 months ago
BCTX POST SPLIT RUN UNDERWAY
👍️0
Monksdream Monksdream 3 months ago
BCTX, new 52 week low
👍️0
Invest-in-America Invest-in-America 4 months ago
BCTX: It's actually GREEN now in price!!! (Heck, maybe there IS a "God" --- of WOMEN, hopefully!!!! And NOT some clown nailed to a cross in Naples, Italy, 2K years ago!!!!)

👍️0
Invest-in-America Invest-in-America 4 months ago
BCTX: I sincerely HOPE that this BCTX stock --- with GREAT news for Women's BREAST Cancer concerns --- gets monster short-SQUEEZED, like below!!! Metaphorically speaking, that is.)

👍️0
shurtha2000 shurtha2000 4 months ago
Slow and Steady up
👍️0
Invest-in-America Invest-in-America 4 months ago
BCTX: The Markets simply do NOT give-a-fluck about WOMEN's issues of any sort!!! (BCTX could have PR'd that they have outright CURED all Breast Cancers, but this stock STILL would not have soared in price!!!)
👍️0
Invest-in-America Invest-in-America 4 months ago
BCTX: The only worrisome thing about anything (Medical) WOMEN's STUFF, is that they rarely if ever SOAR in price. (While mere FLUFF news about anything MEN's Medical issues --- like today's @CADL baloney PR -- often SOAR in price gloriously.)
👍️0
axelvento axelvento 4 months ago
Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated since 2022), double that of comparable patients in the literature
Final Phase 2 OS calculation is pending as many patients remain alive well over 1 year after starting the study
Median OS of 13.7 months in breast cancer patients with central nervous system (CNS) metastasis treated with the Bria-IMT™ regimen alone or in combination with an immune check point inhibitor (CPI)
Five BriaCell posters (four today and one on Dec 13 th ) showcase robust survival and clinical benefit data, plus key biomarker data from Phase 2 trial of Bria-IMT™ in metastatic breast cancer (MBC)
Biomarkers identify patients who benefit from treatments with the Bria-IMT™ regimen
No toxicity related discontinuations



https://feeds.issuerdirect.com/news-release.html?newsid=7743652450762128
👍️0
Invest-in-America Invest-in-America 4 months ago
BCTX: Much more IMPRESSIVE stats. for this BCTX news --- vs. the baloney stats. for @CADL's Prostate Cancer results, which were in truth mere STATISTICAL ARTIFACTS and, as such, significant of NOTHING!!
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
BCTX OUT ON NEWS
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
BCTX MASSIVE NEWS FOR THIS CANADIAN BIO
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
BCTX BLOWING UP
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
BCTX PUSHING TO TOP OF THE DAILY CLOUD VERY NICE
👍️0
glenn1919 glenn1919 4 months ago
BCTX..............................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
BCTX NICE CANADIAN BIO READY FOR A DOLLAR
👍️0
glenn1919 glenn1919 5 months ago
BCTX.........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
axelvento axelvento 6 months ago
HUGE$ In BriaCell's Phase 2 clinical study, patients treated with the same Bria-IMT™ regimen formulation being used in the ongoing Phase 3 pivotal trial experienced a one-year survival rate of 55% (i.e. 55% of patients remain alive at least one year after starting on the study). This rate exceeds the survival data of the current standard of care for similar patients (see Table 1). Notably, 4 of 13 patients recruited in 2022 remain in survival follow-up as well, including:

Patient 01-009: Overall survival (OS) of 25 months has been reported in a patient who had failed 6 prior treatments prior to the BriaCell regimen. Stable disease and lymph node shrinkage has been recorded during 13 cycles of therapy.
Patient 07-001: OS of 24 months. She had stable disease and received 8 cycles of BriaCell's therapy.
Patient 16-003: OS of 15 months and received 8 cycles of therapy with stable disease. Prior to the BriaCell regimen, she had 7 lines of therapy, which included the progression of disease while on the antibody-drug conjugate (ADC) Enhertu.
Patient 11-018: OS of 14 months. This previously-reported responder with 100% resolution of her brain metastasis has recently completed her 19th cycle of therapy.
👍️ 1 ✌️ 1
stocktowatch stocktowatch 6 months ago
$BCTX No serious adverse events related to Bria-IMT™, 35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™, Pivotal Phase 3 study patient enrollment completion is expected in mid-2025

BIG NEWS https://feeds.issuerdirect.com/news-release.html?newsid=7546332967366263
👍 1
glenn1919 glenn1919 6 months ago
BCTX...........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
BCTX.........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 6 months ago
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
👍️0
1hot toddy 1hot toddy 6 months ago
wainwright issues buy on bctx with $15 price $$$$$$$$$$$ cure 4 breast cancer? and others
👍️0
1hot toddy 1hot toddy 6 months ago
Now the co has 8.5 mil for their business plan. Great for co. U got out and missed the push up as co has cure for breast cancer. Stock will rock
👍️0
glenn1919 glenn1919 6 months ago
BCTX........................................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 7 months ago
Gets out now millions of offering shares at .69…12,325,000 common shares. Each common share was sold at an offering price of $0.69 per share, for gross proceeds of approximately $8.5 million,
👎️ 1
glenn1919 glenn1919 7 months ago
BCTX..................................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 7 months ago
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
👍 1
boston127 boston127 7 months ago
Sorry. Wrong Board.
👍️0
Awl416 Awl416 7 months ago
BriaCell Therapeutics Announces $8.5 Million Offering
👍️0
PonkenPlonken PonkenPlonken 7 months ago
aks yourself why no BP wanted to be a part of this. Plenty of time to notice?
👍️0
glenn1919 glenn1919 7 months ago
BCTX..........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783
👍️0
S3lfMade S3lfMade 7 months ago
I'm predicting an offering this week... Company needs cash. Under $1m currently
👍️0